Evidence map›Paper›PMID 25459581›Full record

ReviewImmunology and allergy clinics of North America2015

Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.

Michelle Fox Huffaker, Wanda Phipatanakul

Open access · greenAbstract readReview
In one paragraph

Review in Immunology and allergy clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Taming Asthma in School-Aged Children: A Comprehensive Review.The journal of allergy and clinical immunology. In practice
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michelle Fox HuffakerDivision of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Wanda PhipatanakulDivision of Immunology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. Electronic address: wanda.phipatanakul@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · US

Funding

AsthmaNet: Brigham and Women's Hospital & Children's Hospital BostonU10HL098102 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ISRAEL, ELLIOT, PHIPATANAKUL, WANDA · 2009 to 2015
$5.5M
Midcareer Investigator Award: Urban School Allergen Exposures and Childhood AsthmK24AI106822 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PHIPATANAKUL, WANDA · 2013 to 2022
$1.9M
NHLBI NIH HHS U10 HL098102NIAID NIH HHS K24 AI106822
6 · The paper itself

Abstract

Over the past several decades, the evidence supporting rational pediatric asthma management has grown considerably. As more is learned about the various phenotypes of asthma, the complexity of management will continue to grow. This article focuses on the evidence supporting the current guidelines-based pediatric asthma management and explores the future of asthma management with respect to phenotypic heterogeneity and biologics.

Indexed as

Adrenal Cortex HormonesAnti-Asthmatic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedAsthmaBiological ProductsChildHumansMedication AdherenceNebulizers and VaporizersOmalizumabQuality of LifeAdrenal Cortex HormonesAnti-Asthmatic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedBiological ProductsOmalizumabAsthmaAsthma managementBiologicsOmalizumabPediatric asthma

Identifiers

PMID25459581
PMCPMC4254501
OpenAlexW72340351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.